<SEC-DOCUMENT>0001193125-20-150198.txt : 20200522
<SEC-HEADER>0001193125-20-150198.hdr.sgml : 20200522
<ACCEPTANCE-DATETIME>20200522164614
ACCESSION NUMBER:		0001193125-20-150198
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20200518
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200522
DATE AS OF CHANGE:		20200522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		20906598

	BUSINESS ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		501 CANAL BLVD
		STREET 2:		POINT RICHMOND TECH CNTR.
		CITY:			RICHMOND
		STATE:			CA
		ZIP:			94804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d935677d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20200518" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-05-18_to_2020-05-18">SANGAMO THERAPEUTICS, INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-05-18_to_2020-05-18">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-05-18_to_2020-05-18">0001001233</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2020-05-18_to_2020-05-18" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2020-05-18_to_2020-05-18">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="sgmo-20200518.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-05-18_to_2020-05-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-18</xbrli:startDate> <xbrli:endDate>2020-05-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:9pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-05-18_to_2020-05-18">8-K</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:9pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section 13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:9pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt:datemonthdayyearen">May 18, 2020</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:9pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">SANGAMO THERAPEUTICS, INC.</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:9pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-05-18_to_2020-05-18">000-30171</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-05-18_to_2020-05-18">68-0359556</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">ID Number)</p></td></tr></table>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:9pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:99%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-05-18_to_2020-05-18">7000 Marina Blvd.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-05-18_to_2020-05-18">Brisbane</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-05-18_to_2020-05-18">94005</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices) (Zip Code)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-05-18_to_2020-05-18">(510)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-05-18_to_2020-05-18">970-6000</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s telephone number, including area code)&#160;</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt">Not Applicable</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Former Name or Former Address, if Changed Since Last Report)&#160;</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">Securities registered pursuant to Section 12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:9pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-05-18_to_2020-05-18">Common Stock, $0.01 par value per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-05-18_to_2020-05-18">SGMO</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#32;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:9pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-05-18_to_2020-05-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;5.02 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On May&#160;18, 2020, at the annual meeting of stockholders (the &#8220;Annual Meeting&#8221;) of Sangamo Therapeutics, Inc. (the &#8220;Company&#8221;), the Company&#8217;s stockholders approved the amendment and restatement of the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) to, among other things, increase the number of shares of the Company&#8217;s common stock reserved for issuance under the 2018 Plan by 9,900,000 shares (the &#8220;Amended and Restated 2018 Plan&#8221;). </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Amended and Restated 2018 Plan previously had been approved, subject to stockholder approval, by the Compensation Committee of the Board of Directors of the Company (the &#8220;Board&#8221;). The Amended and Restated 2018 Plan became effective immediately upon stockholder approval at the Annual Meeting. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The terms of the Amended and Restated 2018 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance stock awards that may be settled in cash, stock, or other property. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">A more detailed summary of the material features of the Amended and Restated 2018 Plan, including the terms of stock option and restricted stock unit grants thereunder, are set forth in the Company&#8217;s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April&#160;2, 2020 (the &#8220;Proxy Statement&#8221;). Those summaries and the foregoing descriptions are qualified in their entirety by reference to the full text of the Amended and Restated 2018 Plan which is filed as Exhibit 10.1 hereto and is incorporated herein by reference. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;5.03 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">At the Annual Meeting, the Company&#8217;s stockholders approved and adopted the Fourth Certificate of Amendment (the &#8220;Fourth Certificate of Amendment&#8221;) of the Company&#8217;s Seventh Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from&#160;160,000,000&#160;shares to&#160;320,000,000&#160;shares. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Fourth Certificate of Amendment previously had been approved, subject to stockholder approval, by the Board. </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">A detailed discussion of the Fourth Certificate of Amendment is set forth in the Proxy Statement and a copy thereof is filed as Exhibit 3.1 hereto and is incorporated herein by reference. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;5.07 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Submission of Matters to a Vote of Security Holders.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">At the Annual Meeting, the following proposals were approved by the stockholders: (i)&#160;the election of the nine nominees for director listed in the Proxy Statement to serve on the Board until the next annual meeting of stockholders to be held in 2021 or until their successors are duly elected and qualified; (ii)&#160;the approval, on an advisory basis, of the compensation of the Company&#8217;s named executive officers as disclosed in the Proxy Statement; (iii)&#160;the approval of the Amended and Restated 2018 Plan; (iv)&#160;the approval of the Fourth Certificate of Amendment; and (v)&#160;the ratification of the appointment by the Audit Committee of the Board of Ernst&#160;&#038; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2020, each by the votes set forth below: </p> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Proposal 1: Election of Directors: </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:92%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:60%;"></td>
<td style="width:2%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:2%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:2%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:2%;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of Director </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">For </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Against </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Abstain </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Broker </p> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap">Non-Votes </span> </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Robert F. Carey </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,259,277 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,464,148 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">665,660 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Stephen G. Dilly, M.B.B.S, Ph.D. </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,160,687 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,577,050 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">651,348 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Alexander D. Macrae, M.B., Ch.B., Ph.D. </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,141,331 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,808,368 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">439,386 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">John H. Markels, Ph.D. </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,342,756 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,281,204 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">765,125 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">James R. Meyers </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,309,162 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,301,497 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">778,426 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">H. Stewart Parker </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">55,958,809 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,872,910 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">557,366 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Saira Ramasastry </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">50,356,829 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">8,548,195 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">484,061 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Karen L. Smith, M.D., Ph.D., M.B.A., L.L.M. </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,256,307 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,443,528 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">689,250 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Joseph S. Zakrzewski </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">56,190,486 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,475,464 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">723,135 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:right"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Proposal 2:&#160;Approval, on an advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:84%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:26%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:22%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">For </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Against </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Abstain </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Broker <span style="white-space:nowrap">Non-Votes </span></p> </td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:center;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">53,872,983 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4,906,478 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">609,624 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td> </tr> </table> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Proposal 3:&#160;Approval of the Amended and Restated 2018 Plan: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:84%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:26%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:22%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">For </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Against </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Abstain </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Broker <span style="white-space:nowrap">Non-Votes </span></p> </td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:center;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">49,103,018 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">9,901,759 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">384,308 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">32,529,245 </p> </td> </tr> </table> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Proposal 4:&#160;Approval of the Fourth Certificate of Amendment: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:84%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:26%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:22%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">For </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Against </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Abstain </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Broker <span style="white-space:nowrap">Non-Votes </span></p> </td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:center;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">72,685,331 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">18,376,302 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">856,697 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#8212;&#160;&#160;</p> </td> </tr> </table> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Proposal 5: Ratification of Appointment of Independent Registered Public Accounting Firm: </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:84%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:26%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:23%;"></td>
<td style="width:2%;"></td>
<td style="width:22%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">For </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Against </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Abstain </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Broker <span style="white-space:nowrap">Non-Votes </span></p> </td> </tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:center;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">87,887,748 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2,995,603 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,034,979 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#8212;&#160;&#160;</p> </td> </tr> </table> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d)<span style="font-style:Italic">&#160;Exhibits</span>. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:center;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Exhibit<br />No. </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:left;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;3.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d935677dex31.htm">Fourth Certificate of Amendment of the Seventh Amended and Restated Certificate of Incorporation of Sangamo Therapeutics, Inc. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">10.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d935677dex101.htm">Amended and Restated 2018 Equity Incentive Plan of Sangamo Therapeutics, Inc. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document) </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:45%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:4%;"></td>
<td style="width:1%;"></td>
<td style="width:44%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td colspan="3" style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SANGAMO THERAPEUTICS, INC. </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Dated: May&#160;22, 2020 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ <span style="font-variant:small-caps">Gary H. Loeb</span></p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Gary H. Loeb </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President and General Counsel </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d935677dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOURTH CERTIFICATE OF AMENDMENT OF THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SANGAMO THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>ANGAMO</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>.,</B> a corporation organized and existing under and by virtue of
the General Corporation Law of the State of Delaware, hereby certifies that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F<SMALL>IRST</SMALL>:</B> The name of the Corporation is
Sangamo Therapeutics, Inc. (the &#147;Corporation&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>ECOND</SMALL></B><SMALL></SMALL>: The date of filing of the Seventh
Amended and Restated Certificate of Incorporation of the Corporation with the Secretary of State of the State of Delaware was April&nbsp;11, 2000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIRD</SMALL>:</B> The Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of
the General Corporation Law of the State of Delaware, adopted resolutions further amending its Seventh Amended and Restated Certificate of Incorporation as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Paragraph A of ARTICLE IV of the Corporation&#146;s Seventh Amended and Restated Certificate of Incorporation be, and it hereby is, amended and
restated to read in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;A.&nbsp;&nbsp;&nbsp;&nbsp;<U>Classes of Stock</U>. The total number of shares of stock
which the Corporation shall have authority to issue is three hundred twenty-five million (325,000,000), consisting of five million (5,000,000) shares of Preferred Stock, par value $0.01 per share (the &#147;Preferred Stock&#148;), and three hundred
twenty million (320,000,000) shares of Common Stock, par value $0.01 per share (the &#147;Common Stock&#148;).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>F<SMALL>OURTH</SMALL>:</B> The foregoing amendment was submitted to the stockholders of the Corporation for their approval, and was duly
adopted in accordance with the provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL>, S<SMALL>ANGAMO</SMALL> T<SMALL>HERAPEUTICS</SMALL>,
I<SMALL>NC</SMALL>.</B> has caused this Fourth Certificate of Amendment to be signed by its President and Chief Executive Officer this 18<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of May, 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>S<SMALL>ANGAMO</SMALL> T<SMALL>HERAPEUTICS</SMALL>, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>By:</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g935677ex31.jpg" ALT="LOGO">
</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Alexander D. Macrae, M.B., Ch.B., Ph.D.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>President and Chief Executive Officer</B></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d935677dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sangamo Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2018 Equity Incentive Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adopted by the Compensation Committee of the Board: April&nbsp;23, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approved by the Stockholders: June&nbsp;11, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended and Restated by the Compensation Committee of the Board: March&nbsp;20, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approved by the Stockholders: May&nbsp;18, 2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1. General</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2. Shares Subject to the Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3. Eligibility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4. Options and Stock Appreciation Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5. Awards Other Than Options and Stock Appreciation Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6. Adjustments upon Changes in Common Stock; Other Corporate Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7. Automatic Grants To Eligible Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8. Administration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9. Tax Withholding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10. Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11. Covenants of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12. Additional Rules for Awards Subject to Section&nbsp;409A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13. Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14. Termination of the Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15. Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.<B> General.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Successor to and Continuation of Predecessor Plan.</B> The Plan is the successor to and continuation of the Predecessor Plan. As of the
Effective Date, (i)&nbsp;no additional awards may be granted under the Predecessor Plan; (ii)&nbsp;the Predecessor Plan&#146;s Available Reserve will become available for issuance pursuant to Awards granted under this Plan; and (iii)&nbsp;all
outstanding awards granted under the Prior Plans will remain subject to the terms of the Prior Plans; <I>provided, however</I>, that any Prior Plans&#146; Returning Shares will become available for issuance pursuant to Awards granted under this
Plan. All Awards granted under this Plan will be subject to the terms of this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Eligible Award Recipients and Plan
Purpose.</B> Subject to the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards. Only Eligible Directors will receive Awards under the Automatic Grant Program. The Company, by means of the Plan, seeks to secure and
retain the services of such persons, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases
in value of the Common Stock through the granting of Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Available Awards.</B> The Plan provides for the grant of the
following Awards: (i)&nbsp;Incentive Stock Options; (ii)&nbsp;Nonstatutory Stock Options; (iii)&nbsp;SARs; (iv) Restricted Stock Awards; (v)&nbsp;RSU Awards; (vi)&nbsp;Performance Awards; and (vii)&nbsp;Other Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Effective Date.</B> The Plan will come into existence on the Effective Date. No Award may be granted under the Plan prior to the
Effective Date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.<B> Shares Subject to the Plan.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Share Reserve.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
Subject to the adjustments in this Section&nbsp;2 and in Section&nbsp;6(a), the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed the sum of: (A) 8,800,000 shares (which were approved at the Annual
Meeting in 2018); plus (B) 9,900,000 shares (which were approved at the Annual Meeting in 2020); plus (C)&nbsp;the number of Prior Plans&#146; Returning Shares, if any, as such shares become available from time to time; plus (D) 1,703,964 shares
(which is the Predecessor Plan&#146;s Available Reserve). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The number of shares of Common Stock available for issuance under the Plan will be
reduced by: (A)&nbsp;one share for each share of Common Stock issued pursuant to an Appreciation Award granted under the Plan and (B) 1.33 shares for each share of Common Stock issued pursuant to a Full Value Award granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The number of shares of Common Stock available for issuance under the Plan will be increased by: (A)&nbsp;one share for each Prior
Plans&#146; Returning Share or 2018 Plan Returning Share (as defined in Section&nbsp;2(d)(i)) subject to an Appreciation Award and (B) 1.33 shares for each Prior Plans&#146; Returning Share or 2018 Plan Returning Share (as defined in
Section&nbsp;2(d)(i)) subject to a Full Value Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Incentive Stock Option Limit.</B> Notwithstanding anything to the contrary in
Section&nbsp;2(a) and subject to Section&nbsp;6(a) regarding Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options is 37,400,000 shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Actions that Will Not Constitute Issuance of Shares and Will Not Reduce Share Reserve.</B> The following actions will not result in an
issuance of shares of Common Stock under the Plan and accordingly will not reduce the number of shares of Common Stock subject to the Share Reserve and available for issuance under the Plan: (i)&nbsp;the expiration or termination of any portion of
an Award without the shares covered by such portion of the Award having been issued; or (ii)&nbsp;the settlement of any portion of an Award in cash (i.e., the Participant receives cash rather than shares of Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Reversion of Shares to the Share Reserve.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)<B> Shares Available For Subsequent Issuance.</B> If any shares of Common Stock issued pursuant to an Award are forfeited back to or
repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares, then such shares will revert to the Share Reserve and become available again for issuance under the Plan and, for purposes
of the Plan, such shares will be the &#147;<B><I>2018 Plan Returning Shares</I></B>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)<B> Shares Not Available For Subsequent
Issuance.</B> The following shares of Common Stock will not become available again for issuance under the Plan: (A)&nbsp;any shares that are reacquired or withheld (or not issued) by the Company to satisfy the exercise or purchase price of an
Appreciation Award or a Full Value Award (including any shares subject to such award that are not delivered because such award is exercised through a reduction of shares subject to such award (i.e., &#147;net exercised&#148;)); (B) any shares that
are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Appreciation Award or a Full Value Award; (C)&nbsp;any shares repurchased by the Company on the open market with the proceeds of
the exercise or purchase price of an Appreciation Award or a Full Value Award; and (D)&nbsp;in the event that a Stock Appreciation Right granted under the Plan or a stock appreciation right granted under any of the Prior Plans is settled in shares
of Common Stock, the gross number of shares of Common Stock subject to such award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> Share Reserve Limit.</B> For clarity, the Share
Reserve limit in Section&nbsp;2(a) is a limit on the number of shares of Common Stock that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available at all times the number of shares of
Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such Awards. Shares may be issued in connection with a merger or acquisition as permitted by, as applicable, Nasdaq Listing Rule 5635(c), NYSE Listed Company
Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.<B> Eligibility.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Eligibility for
Specific Awards.</B> Incentive Stock Options may be granted only to Employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections 424(e) and (f)&nbsp;of the Code).
Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <I>provided, however</I>, that Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and Consultants who are providing
Continuous Service only to any &#147;parent&#148; of the Company (as such term is defined in Rule&nbsp;405) unless the stock underlying such Awards is treated as &#147;service recipient stock&#148; under Section&nbsp;409A because the Awards are
granted pursuant to a corporate transaction (such as a spin off transaction) or unless such Awards otherwise comply with the distribution requirements of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Ten Percent Stockholders.</B> A Ten Percent Stockholder may not be granted an Incentive Stock Option unless (i)&nbsp;the exercise price
of such Option is at least 110% of the Fair Market Value on the date of grant of such Option and (ii)&nbsp;the Option is not exercisable after the expiration of five years from the date of grant of such Option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.<B> Options and Stock Appreciation Rights.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option and SAR will have such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive
Stock Option or Nonstatutory Stock Option at the time of grant; <I>provided, however</I>, that if an Option is not so designated, then such Option will be a Nonstatutory Stock Option, and the shares purchased upon exercise of each type of Option
will be separately accounted for. The terms and conditions of separate Options and SARs need not be identical; <I>provided, however</I>, that each Option Agreement and SAR Agreement will conform (through incorporation of provisions hereof by
reference in the Award Agreement or otherwise) to the substance of each of the following provisions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Term.</B> Subject to
Section&nbsp;3(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Exercise or Strike Price.</B> Subject to Section&nbsp;3(b) regarding Ten Percent
Stockholders, the exercise or strike price of each Option or SAR will not be less than 100% of the Fair Market Value on the date of grant of such Award. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price
lower than 100% of the Fair Market Value on the date of grant of such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Change in Control and in a manner
consistent with the provisions of Sections 409A and, if applicable, 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Exercise Procedure and Payment of Exercise Price for Options.</B> In order to exercise an Option, the Participant must provide notice
of exercise to the Plan Administrator in accordance with the procedures specified in the Option Agreement. The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to
use certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment. The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by the Board, by
one or more of the following methods of payment to the extent set forth in the Option Agreement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) by cash or check, bank draft or
money order payable to the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) pursuant to a &#147;cashless exercise&#148; program developed under Regulation T as promulgated
by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the exercise price to the Company
from the sales proceeds; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are
already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A)&nbsp;at the time of exercise the
Common Stock is publicly traded, (B)&nbsp;any remaining balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form of payment, (C)&nbsp;such delivery would not violate any Applicable Law
or agreement restricting the redemption of the Common Stock, (D)&nbsp;any certificated shares are endorsed or accompanied by an executed assignment separate from certificate, and (E)&nbsp;such shares have been held by the Participant for any minimum
period necessary to avoid adverse accounting treatment as a result of such delivery; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) if the Option is a Nonstatutory Stock Option,
by a &#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not
exceed the exercise price, provided that (A)&nbsp;any remaining balance of the exercise price not satisfied by such net exercise is paid by the Participant in cash or other permitted form of payment, and (B)&nbsp;shares of Common Stock will no
longer be subject to such Option and will not be exercisable thereafter to the extent that shares issuable upon exercise are reduced to pay the exercise price pursuant to such &#147;net exercise;&#148; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) in any other form of consideration that may be acceptable to the Board and permissible under Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Exercise Procedure and Payment of Appreciation Distribution for SARs.</B> In order to exercise any SAR, the Participant must provide
notice of exercise to the Plan Administrator in accordance with the SAR Agreement. The appreciation distribution payable to a Participant upon the exercise of a SAR will not be greater than an amount equal to the excess of (i)&nbsp;the aggregate
Fair Market Value on the date of exercise of a number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and being exercised under such SAR, over (ii)&nbsp;the strike price of such SAR. Such appreciation
distribution may be paid to the Participant in the form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment, as determined by the Board and specified in the SAR Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> Transferability.</B> Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such
additional limitations on the transferability of an Option or SAR. In the absence of any such determination, the following restrictions on the transferability of Options and SARs will apply, provided that except as explicitly provided herein,
neither an Option nor a SAR may be transferred for consideration and <I>provided, further</I>, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)<B> Restrictions on Transfer.</B> An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and
will be exercisable during the lifetime of the Participant only by the Participant; <I>provided, however</I>, that the Board may permit transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the
Participant&#146;s request, including to a trust if the Participant is considered to be the sole beneficial owner of such trust (as determined under Section&nbsp;671 of the Code and applicable state law) while such Option or SAR is held in such
trust, provided that the Participant and the trustee enter into a transfer and other agreements required by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)<B> Domestic Relations Orders.</B> Notwithstanding the foregoing, subject to the
execution of transfer documentation in a format acceptable to the Company, an Option or SAR may be transferred pursuant to a domestic relations order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)<B> Vesting.</B> Subject to Section&nbsp;10(a), the Board may impose such restrictions on or conditions to the vesting and/or
exercisability of an Option or SAR as determined by the Board and which may vary. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Options and SARs will
cease upon termination of the Participant&#146;s Continuous Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)<B> Termination of Continuous Service.</B> Subject to
Section&nbsp;4(h), if a Participant&#146;s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her Option or SAR to the extent vested, but only within the following period of time or, if applicable,
such other period of time provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate; <I>provided, however</I>, that in no event may such Award be exercised after the expiration of its maximum
term (as set forth in Section&nbsp;4(a)): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) three months following the date of such termination if such termination is a termination
without Cause (other than any termination due to the Participant&#146;s Disability or death); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) 12 months following the date of such
termination if such termination is due to the Participant&#146;s Disability; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) 18 months following the date of such termination if
such termination is due to the Participant&#146;s death; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) 18 months following the date of the Participant&#146;s death if such
death occurs following the date of such termination but during the period such Award is otherwise exercisable (as provided in (i)&nbsp;or (ii) above). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the date of such termination, to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or,
if earlier, prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant will have no further right, title or interest in the terminated Award, the shares of Common Stock
subject to the terminated Award, or any consideration in respect of the terminated Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)<B> Extension of Exercisability.</B> Except
as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates for any reason other than for Cause and, at any time during the last
thirty days of the applicable Post-Termination Exercise Period: (i)&nbsp;the exercise of the Participant&#146;s Option or SAR would be prohibited solely because the issuance of shares of Common Stock upon such exercise would violate Applicable Law,
or (ii)&nbsp;the immediate sale of any shares of Common Stock issued upon such exercise would violate the Company&#146;s Trading Policy, then the applicable Post-Termination Exercise Period will be extended to the last day of the calendar month that
commences following the date the Award would otherwise expire, with an additional extension of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time during such extended
exercise period, generally without limitation as to the maximum permitted number of extensions); <I>provided, however</I>, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section&nbsp;4(a)).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)<B> Termination of Continuous Service for Cause.</B> Except as explicitly otherwise provided in the Award Agreement or other written
agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service is terminated for Cause, the Participant&#146;s Options and SARs will terminate and be forfeited immediately upon such termination of
Continuous Service, and the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date of such termination of Continuous Service and the Participant will have no further right,
title or interest in such forfeited Award, the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)<B> <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employees.</B> No Option or SAR, whether or not vested, granted to an Employee who
is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the Fair Labor Standards Act of 1938, as amended, will be first exercisable for any shares of Common Stock until at least six months following the date of grant of such
Award. Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such Award in the event of
(i)&nbsp;such Participant&#146;s death or Disability, (ii)&nbsp;a Change in Control in which such Award is not assumed, continued or substituted, or (iii)&nbsp;such Participant&#146;s retirement (as such term may be defined in the Award Agreement or
another applicable agreement or, in the absence of any such definition, in accordance with the Company&#146;s then current employment policies and guidelines). This Section&nbsp;4(j) is intended to operate so that any income derived by a <FONT
STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)<B> Whole Shares.</B> Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.<B> Awards Other Than Options and Stock Appreciation Rights.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Restricted Stock Awards and RSU Awards.</B> Each Restricted Stock Award and RSU Award will have such terms and conditions as determined
by the Board. The terms and conditions of separate Restricted Stock Awards and RSU Awards need not be identical; <I>provided, however</I>, that each Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation of the
provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)<B> Form of
Award.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) To the extent consistent with the Company&#146;s Bylaws, at the Board&#146;s election, shares of Common Stock subject to
a Restricted Stock Award may be (i)&nbsp;held in book entry form subject to the Company&#146;s instructions until such shares become vested or any other restrictions lapse, or (ii)&nbsp;evidenced by a certificate, which certificate will be held in
such form and manner as determined by the Board. Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder of the Company with respect to any shares subject to a Restricted Stock Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) A RSU Award represents a Participant&#146;s right to be issued on a future date the number of shares of Common Stock that is equal to the
number of restricted stock units subject to the RSU Award. As a holder of a RSU Award, a Participant is an unsecured creditor of the Company with respect to the Company&#146;s unfunded obligation, if any, to issue shares of Common Stock in
settlement of such Award and nothing contained in the Plan or any RSU Award Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between a Participant and
the Company or an Affiliate or any other person. A Participant will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award (unless and until shares are actually issued in settlement of a vested RSU Award).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)<B> Consideration.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) A Restricted Stock Award may be granted in consideration for (A)&nbsp;cash or check, bank draft or money order payable to the Company,
(B)&nbsp;past services to the Company or an Affiliate, or (C)&nbsp;any other form of consideration (including future services) as the Board may determine and permissible under Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant&#146;s
services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common
Stock pursuant to the RSU Award. If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form other than the Participant&#146;s services to the Company or an Affiliate) upon the issuance of any
shares of Common Stock in settlement of the RSU Award, such consideration may be paid in any form of consideration as the Board may determine and permissible under Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)<B> Vesting.</B> Subject to Section&nbsp;10(a), the Board may impose such restrictions on or conditions to the vesting of a Restricted
Stock Award or RSU Award as determined by the Board and which may vary. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU
Awards will cease upon termination of the Participant&#146;s Continuous Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv)<B> Termination of Continuous Service.</B> Except as
otherwise provided in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#146;s Continuous Service terminates for any reason, (i)&nbsp;the Company may receive through a forfeiture
condition or a repurchase right any or all of the shares of Common Stock held by the Participant under his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock Award Agreement and
(ii)&nbsp;any portion of his or her RSU Award that has not vested will be forfeited upon such termination and the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to the RSU
Award, or any consideration in respect of the RSU Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)<B> Settlement of RSU Awards.</B> A RSU Award may be settled by the issuance
of shares of Common Stock or cash (or any combination thereof) or in any other form of payment, as determined by the Board and specified in the RSU Award Agreement. At the time of grant, the Board may determine to impose such restrictions or
conditions that delay such delivery to a date following the vesting of the RSU Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Performance Awards.</B> With respect to any
Performance Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, the other terms and conditions of such Award, and the measure of whether and to what degree such Performance Goals have been
attained will be determined by the Board. In addition, to the extent permitted by Applicable Law and set forth in the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Other Awards.</B> Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock may be granted
either alone or in addition to Awards provided for under Section&nbsp;4 and the preceding provisions of this Section&nbsp;5. Subject to the provisions of the Plan, the Board will have sole and complete discretion to determine the persons to whom and
the time or times at which such Other Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.<B> Adjustments upon Changes in Common Stock; Other Corporate Events.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Capitalization Adjustments.</B> In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust:
(i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;2(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to
Section&nbsp;2(b), (iii) the class(es) and number of securities to be granted pursuant to the Automatic Grant Program, and (iv)&nbsp;the class(es) and number of securities and exercise price, strike price or purchase price of stock subject to
outstanding Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. Notwithstanding the provisions of this Section&nbsp;6(a), no fractional shares or rights for fractional shares of Common Stock
shall be created pursuant to this Section&nbsp;6(a). The Board shall determine an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments referred to in this Section&nbsp;6(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Dissolution or Liquidation.</B> Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of
the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to the completion of
such dissolution or liquidation, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such
Award is providing Continuous Service, <I>provided, however</I>, that the Board may determine to cause some or all Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not
previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Change in
Control.</B> The following provisions will apply to Awards in the event of a Change in Control unless otherwise provided in the instrument evidencing the Award or any other written agreement between the Company or any Affiliate and the Participant
or unless otherwise expressly provided by the Board at the time of grant of the Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)<B> Awards May Be Assumed.</B> In the event of
a Change in Control, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute similar stock awards for
Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Change in Control), and any reacquisition or repurchase rights held by the Company in
respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or the successor&#146;s parent company, if any), in connection with such Change in Control. A surviving corporation or acquiring
corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar stock award for only a portion of a Award, or may choose to assume or continue the Awards held by some, but not all Participants. The
terms of any assumption, continuation or substitution will be set by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)<B> Awards Held by Current Eligible Participants.</B>
In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards, then with respect
to Awards that have not been assumed, continued or substituted and that are held by Participants who are Employees or Directors and whose Continuous Service has not terminated prior to the effective time of the Change in Control (referred to as the
&#147;<B><I>Current Eligible Participants</I></B>&#148;), the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may be exercised) will be accelerated in full to a date prior to the
effective time of such Change in Control (contingent upon the effectiveness of the Change in Control) as the Board determines (or, if the Board does not determine such a date, to the date that is five (5)&nbsp;days prior to the effective time of the
Change in Control), and such Awards will terminate if not exercised (if applicable) at or prior to the effective time of the Change in Control, and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse
(contingent upon the effectiveness of the Change in Control). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)<B> Awards Held by Persons other than Current Eligible
Participants.</B> In the event of a Change in Control in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar stock awards for such outstanding
Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held by persons other than Current Eligible Participants, such Awards will terminate if not exercised (if applicable) prior to the effective time
of the Change in Control; <I>provided, however</I>, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv)<B> Payment for Awards in Lieu of Exercise.</B> Notwithstanding the foregoing, in the event a Award will terminate if not exercised prior
to the effective time of a Change in Control, the Board may provide, in its sole discretion, that the holder of such Award may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the
effective time, to the excess, if any, of (A)&nbsp;the value of the property the Participant would have received upon the exercise of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (B)&nbsp;any
exercise price payable by such holder in connection with such exercise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Appointment of Stockholder Representative.</B> As a condition to the receipt of an
Award under this Plan, a Participant will be deemed to have agreed that the Award will be subject to the terms of any agreement governing a Change in Control involving the Company, including, without limitation, a provision for the appointment of a
stockholder representative that is authorized to act on the Participant&#146;s behalf with respect to any escrow, indemnities and any contingent consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> No Restriction on Right to Undertake Transactions.</B> The grant of any Award under the Plan and the issuance of shares pursuant to any
Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#146;s capital structure or its
business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the
rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether
of a similar character or otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.<B> Automatic Grants To Eligible Directors.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> General.</B> The Automatic Grant Program set forth in this Section&nbsp;7 provides that Eligible Directors shall automatically receive
the grant of certain Awards at designated intervals over their period of Continuous Service on the Board. For the avoidance of doubt, Awards granted under this Automatic Grant Program are subject to all the terms and conditions of the Plan. Each
Option granted under this Automatic Grant Program shall (i)&nbsp;be a Nonstatutory Stock Option, (ii)&nbsp;have an exercise price equal to one hundred percent (100%) of the Fair Market Value on the date the Option is granted, and (iii)&nbsp;have a
maximum term of 10 years. For the avoidance of doubt, any shares of Common Stock issued pursuant to Awards granted under the Automatic Grant Program which may vest any earlier than 12 months following the date of grant will count against the 5%
permitted exception to the minimum vesting requirements set forth in Section&nbsp;10(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Initial Awards.</B> If an Eligible
Director is first elected or appointed to serve on the Board on or after the Annual Meeting in 2020, such person shall, upon the date of his or her initial election or appointment as an Eligible Director, be granted an Option to purchase 30,000
shares of Common Stock and a RSU Award in respect of 15,000 shares of Common Stock (each such Option and RSU Award an &#147;<B><I>Initial Award</I></B>&#148;). Initial Awards of Options shall vest monthly with respect to 1/36th of the shares over
the three year period following the date of grant, subject to the Eligible Director&#146;s Continuous Service through the applicable vesting dates, so that the Option will be fully vested on the third anniversary of the date of grant. Initial Awards
of RSU Awards shall vest annually with respect to 1/3rd of the shares over the three year period following the date of grant, subject to the Eligible Director&#146;s Continuous Service through the applicable vesting dates, so that the RSU Award is
fully vested on the third anniversary of the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Annual Awards.</B> Each person who is an Eligible Director shall be
granted an Option to purchase 20,000 shares of Common Stock and a RSU Award in respect of 10,000 shares of Common Stock (each such Option and RSU Award, an &#147;<B><I>Annual Award</I></B>&#148;) on an annual basis as follows: (i)&nbsp;with respect
to 2020, such Annual Awards shall be granted on the date of the Annual Meeting in 2020; and (ii)&nbsp;with respect to each year following 2020, such Annual Awards shall be granted on the 25th day of February of such year (or if such 25th day is not
a trading day, the immediately preceding trading day in February); in each case, provided that such person is an Eligible Director on the date of grant, has served as an Eligible Director for a period of at least three months prior to the date of
grant, and will continue serving as an Eligible Director immediately after the date of grant. Annual Awards of Options shall vest monthly with respect to 1/12th of the shares over the one (1)&nbsp;year period following the date of grant, subject to
the Eligible Director&#146;s Continuous Service through the applicable vesting dates, so that the Option will be fully vested on the first anniversary of the date of grant. Annual Awards of RSU Awards granted in 2020 shall fully vest on the earlier
of (i)&nbsp;the first anniversary of the date of grant or (ii)&nbsp;the day prior to the next Annual Meeting, subject to the Eligible Director&#146;s Continuous Service through such date. Annual Awards of RSU Awards granted in each year following
2020 shall fully vest on the first anniversary of the date of grant, subject to the Eligible Director&#146;s Continuous Service through such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Vesting Upon Change in Control or Hostile Take-Over.</B> Each Option and RSU Award granted pursuant to this Automatic Grant Program
shall automatically fully accelerate vesting immediately prior to the effectiveness of a Change in Control or Hostile Take-Over, subject to the Eligible Director&#146;s Continuous Service through the date of the Change in Control or Hostile
Take-Over, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> Vesting Upon Death or Disability.</B> If the Eligible Director&#146;s Continuous Service terminates due
to death or Disability, such Eligible Director&#146;s Options and RSU Awards granted pursuant to this Automatic Grant Program shall automatically fully vest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.<B> Administration.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Administration by Board.</B> The Board will administer the Plan unless and until the Board delegates administration of the Plan to a
Committee or Committees, as provided in Section&nbsp;8(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Powers of Board.</B> Except with respect to the Automatic Grant
Program, the Board shall have the power, subject to, and within the limitations of, the express provisions of the Plan: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To determine
from time to time (A)&nbsp;which of the persons eligible under the Plan will be granted Awards; (B)&nbsp;when and how each Award will be granted; (C)&nbsp;what type or combination of types of Award will be granted; (D)&nbsp;the provisions of each
Award granted (which need not be identical), including the time or times when a person will be permitted to receive cash or Common Stock pursuant to an Award; (E)&nbsp;the number of shares of Common Stock with respect to which an Award will be
granted to each such person; and (F)&nbsp;the Fair Market Value applicable to an Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) To construe and interpret the Plan and
Awards granted under it, and to establish, amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement in a manner
and to the extent it deems necessary or expedient to make the Plan or Award fully effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To settle all controversies regarding
the Plan and Awards granted under it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) To accelerate the time at which an Award may first be exercised or the time during which an
Award or any part thereof will vest, notwithstanding the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest, including in connection with a Change in Control or Hostile
Take-Over. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) To prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to thirty days prior to the
consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of
Common Stock or the share price of the Common Stock including any Change in Control, for reasons of administrative convenience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) To
suspend or terminate the Plan at any time. Suspension or termination of the Plan will not impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) To amend the Plan in any respect the Board deems necessary or advisable, provided that stockholder approval will be required to the
extent required by Applicable Law. Except as provided above, rights under any Award granted before amendment of the Plan will not be impaired by any amendment of the Plan unless (1)&nbsp;the Company requests the consent of the affected Participant,
and (2)&nbsp;such Participant consents in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) To submit any amendment to the Plan for stockholder approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited
to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided, however</I>, that except with
respect to amendments that disqualify or impair the status of an Incentive Stock Option, a Participant&#146;s rights under any Award will not be impaired by any such amendment unless (A)&nbsp;the Company requests the consent of the affected
Participant, and (B)&nbsp;such Participant consents in writing. Notwithstanding the foregoing, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that
the amendment, taken as a whole, does not materially impair the Participant&#146;s rights, including, but not limited, to, an amendment that imposes reasonable restrictions on the minimum number of shares subject to an Option that may be exercised,
and (2)&nbsp;subject to the limitations of Applicable Law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#146;s consent (A)&nbsp;to maintain the qualified status of the Award as an Incentive Stock
Option under Section&nbsp;422 of the Code; (B)&nbsp;to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under
Section&nbsp;422 of the Code; (C)&nbsp;to clarify the manner of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section&nbsp;409A; or (D)&nbsp;to comply with other Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the
Company and that are not in conflict with the provisions of the Plan or Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) To adopt such procedures and <FONT
STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Administration of Automatic Grant Program.</B> The Board shall have the power, subject to and within the limitations of, the express
provisions of the Automatic Grant Program: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) To determine the provisions of each Award to the extent not specified in the Automatic
Grant Program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) To construe and interpret the Automatic Grant Program and the Awards granted under it, and to establish, amend and
revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Automatic Grant Program or in any Award Agreement, in a manner and to the extent it shall deem
necessary or expedient to make the Automatic Grant Program fully effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To amend the terms of the Automatic Grant Program or an
Award granted thereunder, except that rights under any such Award granted before amendment of the Automatic Grant Program shall not be impaired by any amendment of the Automatic Grant Program unless (1)&nbsp;the Company requests the consent of the
affected Participant, and (2)&nbsp;such Participant consents in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Generally, to exercise such powers and to perform such acts
as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Automatic Grant Program. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Delegation to Committee.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)<B> General.</B> The Board may delegate some or all of the administration of the Plan (except the Automatic Grant Program) to a Committee or
Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the
power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such
resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Committee may, at any time, abolish the subcommittee and/or revest in the Committee any powers delegated to the subcommittee. The
Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. As of the Effective Date the Board has delegated administration of the
Plan to the Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)<B> Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Compliance.</B> The Committee may consist
solely of two or more <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> In addition, the Board or the Committee, in its sole discretion, may delegate to a Committee
who need not be <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors the authority to grant Awards to eligible persons who are not then subject to Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> Effect of Board&#146;s Decision.</B> All determinations, interpretations and constructions made by the Board or any Committee in good
faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)<B> Cancellation and <FONT
STYLE="white-space:nowrap">Re-Grant</FONT> of Awards.</B> Neither the Board nor any Committee will have the authority to: (i)&nbsp;reduce the exercise price or strike price of any outstanding Options or SARs under the Plan, or (ii)&nbsp;cancel any
outstanding Options or SARs that have an exercise price or strike price greater than the current Fair Market Value in exchange for cash or other Awards under the Plan, unless the stockholders of the Company have approved such an action within twelve
months prior to such an event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)<B> Delegation to an Officer.</B> The Board or any Committee may delegate to one or more Officers the
authority to do one or both of the following (i)&nbsp;designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable Law, other Awards) and, to the extent permitted by Applicable Law, the
terms thereof, and (ii)&nbsp;determine the number of shares of Common Stock to be subject to such Awards granted to such Employees; <I>provided, however,</I> that the resolutions evidencing such delegation will specify the total number of shares of
Common Stock that may be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Any such Awards will be granted on the form of Award Agreement most recently approved for use by the Board or
the Committee, unless otherwise provided in the resolutions approving the delegation authority. Notwithstanding anything to the contrary herein, neither the Board nor any Committee may delegate to an Officer who is acting solely in the capacity of
an Officer (and not also as a Director) the authority to determine the Fair Market Value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.<B> Tax Withholding</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Withholding Authorization.</B> As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from
payroll and any other amounts payable to such Participant, and otherwise agree to make adequate provision for (including), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an Affiliate,
if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable. Accordingly, a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to
issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Satisfaction of Withholding
Obligation.</B> To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state, local or foreign tax withholding obligation relating to an Award by any of the following means or by a
combination of such means: (i)&nbsp;causing the Participant to tender a cash payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Award; (iii)&nbsp;withholding cash from an Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; (v)&nbsp;by means of a &#147;cashless
exercise&#148; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; or (vi)&nbsp;by such other method as may be set forth in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Withholding Indemnification.</B> As a condition to accepting an Award under the Plan, in the event that the amount of the
Company&#146;s withholding obligation in connection with such Award was greater than the amount actually withheld by the Company, each Participant agrees to indemnify and hold the Company harmless from any failure by the Company to withhold the
proper amount. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.<B> Miscellaneous.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Minimum Vesting Requirements.</B> No Award may vest (or, if applicable, be exercisable) until at least twelve (12)&nbsp;months following
the date of grant of the Award; <I>provided, however</I>, that shares of Common Stock up to five percent (5%) of the Share Reserve may be issued pursuant to Awards that do not meet such vesting (and, if applicable, exercisability) requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> Dividends and Dividend Equivalents.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Dividends or dividend equivalents may not be paid or credited to Options or SARs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) With respect to any Award other than an Option or SAR, dividends or dividend equivalents may be paid or credited, as applicable, with
respect to any shares of Common Stock subject to such Award, as determined by the Board and specified in the applicable Award Agreement; <I>provided, however</I>, that (i)&nbsp;no dividends or dividend equivalents may be paid with respect to any
such shares before the date such shares have vested under the terms of such Award Agreement, (ii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions
applicable to such shares under the terms of such Award Agreement (including, but not limited to, any vesting conditions), and (iii)&nbsp;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to
the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Source of Shares.</B> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B> Use of Proceeds from Sales of Common Stock.</B> Proceeds from
the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)<B> Corporate Action Constituting
Grant of Awards.</B> Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving
the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related
grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)<B> Stockholder Rights.</B> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to such Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of the Award pursuant to its terms, if applicable, and (ii)&nbsp;the issuance of the Common Stock subject to such
Award is reflected in the records of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)<B> No Employment or Other Service Rights.</B> Nothing in the Plan, any Award
Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the
Award was granted or affect the right of the Company or an Affiliate to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award (i)&nbsp;the employment of an Employee with or
without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of such Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the Bylaws of the Company
or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. Further, nothing in the Plan, any Award Agreement or any other instrument executed thereunder
or in connection with any Award will constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or
service or confer any right or benefit under the Award or the Plan unless such right or benefit has specifically accrued under the terms of the Award Agreement and/or Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)<B> Change in Time Commitment.</B> In the event a Participant&#146;s regular level of time commitment in the performance of his or her
services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an extended leave of absence) after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law, to (x)&nbsp;make a corresponding
reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a reduction,
extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)<B> Incentive Stock Option $100,000 Limitation.</B> To the extent that the aggregate Fair Market Value (determined at the time of grant) of
Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the
Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be
treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)<B> Execution of
Additional Documents.</B> As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional documents or instruments necessary or desirable, as determined in the Plan Administrator&#146;s sole discretion, to carry
out the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case at the Plan Administrator&#146;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)<B> Electronic Delivery and Participation.</B> Any reference herein or in an Award Agreement to a &#147;written&#148; agreement or document
will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium controlled by the Company to which the
Participant has access). By accepting any Award the Participant consents to receive documents by electronic delivery and to participate in the Plan through any <FONT STYLE="white-space:nowrap">on-line</FONT> electronic system established and
maintained by the Plan Administrator or another third party selected by the Plan Administrator. The form of delivery of any Common Stock (<I>e.g.</I>, a stock certificate or electronic entry evidencing such shares) shall be determined by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)<B> Clawback/Recovery.</B> All Awards granted under the Plan will be subject to recoupment in accordance with any clawback
policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and
Consumer Protection Act or other Applicable Law, and any other clawback policy that the Company adopts. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary
or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an
event giving rise to a Participant&#146;s right to voluntary terminate employment upon a &#147;resignation for good reason,&#148; or for a &#147;constructive termination&#148; or any similar term under any plan of or agreement with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)<B> Securities Law Compliance.</B> A Participant will not be issued any shares in respect of an Award unless either (i)&nbsp;the shares are
registered under the Securities Act; or (ii)&nbsp;the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Each Award also must comply with other Applicable Law governing the Award, and
a Participant will not receive such shares if the Company determines that such receipt would not be in material compliance with Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)<B> Transfer or Assignment of Awards; Issued Shares.</B> Except as expressly provided in the Plan or the form of Award Agreement, Awards
granted under the Plan may not be transferred or assigned by the Participant. After the vested shares subject to an Award have been issued, or in the case of Restricted Stock and similar awards, after the issued shares have vested, the holder of
such shares is free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein, the terms of the Trading Policy and Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)<B> Effect on Other Employee Benefit Plans.</B> The value of any Award granted under the Plan, as determined upon grant, vesting or
settlement, shall not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant&#146;s benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan
otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#146;s or any Affiliate&#146;s employee benefit plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)<B> Deferrals.</B> To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common
Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may also establish programs and procedures for deferral elections to be made by Participants. Deferrals by will be made in
accordance with the requirements of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)<B> Section 409A.</B> Unless otherwise expressly provided for in an Award
Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&nbsp;409A, and, to the extent not so exempt, in compliance with the
requirements of Section&nbsp;409A. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&nbsp;409A, the Award Agreement evidencing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms
necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock
are publicly traded, and if a Participant holding an Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A is a &#147;specified employee&#148; for purposes of Section&nbsp;409A, no distribution or payment of any amount
that is due because of a &#147;separation from service&#148; (as defined in Section&nbsp;409A without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such
Participant&#146;s &#147;separation from service&#148; or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with Section&nbsp;409A, and any amounts so deferred will be
paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)<B> Data
Privacy.</B> By accepting an Award granted under the Plan, a Participant thereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of such Participant&#146;s personal data as described herein by
and among, as applicable, the Employer, and the Company and its other Affiliates and the Plan Administrator for the exclusive purpose of implementing, administering and managing such Participant&#146;s participation in the Plan. Each Participant
understands that the Company and the Employer may hold certain personal information about such Participant, including, but not limited to, the Participant&#146;s name, home address and telephone number, date of birth, social insurance number or
other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to ordinary shares awarded, canceled, exercised, vested, unvested or outstanding in
the Participant&#146;s favor, for the purpose of implementing, administering and managing the Plan (the &#147;<B><I>Data</I></B>&#148;). Each Participant understands that Data may be transferred to any third parties assisting in the implementation,
administration and management of the Plan, that these recipients may be located in the Participant&#146;s country or elsewhere, and that the recipients&#146; country (<I>e.g</I>., the United States) may have different data privacy laws and
protections than the Participant&#146;s country. Each Participant understands that such Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant&#146;s local human resources
representative. Each Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant&#146;s participation in
the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom such Participant may elect to deposit any ordinary shares acquired pursuant to an Award. Each Participant understands that Data
will be held only as long as is necessary to implement, administer and manage such Participant&#146;s participation in the Plan. Each Participant understands that such Participant may, at any time, view Data, request additional information about the
storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, without cost, by contacting in writing such Participant&#146;s local human resources representative. Each Participant understands,
however, that refusing or withdrawing such Participant&#146;s consent may affect such Participant&#146;s ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, each Participant
understands that such Participant may contact his or her local human resources representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)<B> Choice of Law.</B> This Plan and
any controversy arising out of or relating to this Plan shall be governed by, and construed in accordance with, the internal laws of the State of California, without regard to conflict of law principles that would result in any application of any
law other than the law of the State of California. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.<B> Covenants of the Company.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Securities Law Compliance.</B> The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the
Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards; <I>provided, however</I>, that this undertaking will not require the Company to register under the Securities Act the
Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary
for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained. A Participant is
not eligible for the grant of an Award or the subsequent issuance of Common Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> No Obligation to Notify or Minimize Taxes; No Liability for Taxes.</B> The Company has no duty or obligation to any Participant to
advise such holder as to the time or manner of exercising such Award. Furthermore, the Company has no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the
Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in connection
with an Award. As a condition to accepting an Award under the Plan, each Participant (i)&nbsp;agrees to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from such
Award or other Company compensation and (ii)&nbsp;acknowledges that such Participant was advised to consult with his or her own personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or
knowingly and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voluntarily declined to do so. Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt from Section&nbsp;409A only if the exercise or strike price is at
least equal to the &#147;fair market value&#148; of the Common Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with the Award. Additionally, as a
condition to accepting an Option or SAR granted under the Plan, each Participant agrees not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the Internal Revenue Service asserts that
such exercise price or strike price is less than the &#147;fair market value&#148; of the Common Stock on the date of grant as subsequently determined by the Internal Revenue Service. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12.<B> Additional Rules for Awards Subject to Section</B><B></B><B>&nbsp;409A.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<B> Application.</B> Unless the provisions of this Section&nbsp;12 of the Plan are expressly superseded by the provisions in the form of
Award Agreement, the provisions of this Section&nbsp;12 shall apply and shall supersede anything to the contrary set forth in the Award Agreement for a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)<B> <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards Subject to <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance
Arrangements.</B> To the extent a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award is subject to Section&nbsp;409A due to application of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, the following provisions of
Section&nbsp;12(b) apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award vests in the ordinary course during the
Participant&#146;s Continuous Service in accordance with the vesting schedule set forth in the Award Agreement, and does not accelerate vesting under the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, in no
event will the shares be issued in respect of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award any later than the later of: (i)&nbsp;December 31st of the calendar year that includes the applicable vesting date, or (ii)&nbsp;the 60th day
that follows the applicable vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If vesting of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award accelerates
under the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement in connection with the Participant&#146;s Separation from Service, and such vesting acceleration provisions were in effect as of the date of grant of the <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award and, therefore, are part of the terms of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award as of the date of grant, then the shares will be earlier issued in settlement of such <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award upon the Participant&#146;s Separation from Service in accordance with the terms of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement, but in no event later than the 60<SUB
STYLE="font-size:85%; vertical-align:bottom">th</SUB> day that follows the date of the Participant&#146;s Separation from Service. However, if at the time the shares would otherwise be issued the Participant is subject to the distribution
limitations contained in Section&nbsp;409A applicable to &#147;specified employees,&#148; as defined in Section&nbsp;409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that is six months following the date of such
Participant&#146;s Separation from Service, or, if earlier, the date of the Participant&#146;s death that occurs within such six month period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If vesting of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award accelerates under the terms of a
<FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement in connection with a Participant&#146;s Separation from Service, and such vesting acceleration provisions were not in effect as of the date of grant of the Non-Exempt Award
and, therefore, are not a part of the terms of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award on the date of grant, then such acceleration of vesting of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall not accelerate
the issuance date of the shares, but the shares shall instead be issued on the same schedule as set forth in the Grant Notice as if they had vested in the ordinary course during the Participant&#146;s Continuous Service, notwithstanding the vesting
acceleration of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Such issuance schedule is intended to satisfy the requirements of payment on a specified date or pursuant to a fixed schedule, as provided under Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-3(a)(4).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)<B> Treatment of <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Awards Upon a Change in Control for Employees and Consultants.</B> The provisions of this Section&nbsp;12(c) shall apply and shall supersede anything to the contrary set forth in the Plan with respect to the permitted treatment of any <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award in connection with a Change in Control if the Participant was either an Employee or Consultant upon the applicable date of grant of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards: The following provisions shall apply to any Vested <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award in connection with a Change in Control: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) If the Change in Control is also a
Section&nbsp;409A Change of Control, then the Acquiring Entity may not assume, continue or substitute the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Upon the Section&nbsp;409A Change of Control the settlement of the Vested <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award will automatically be accelerated and the shares will be immediately issued in respect of the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Alternatively, the Company may instead
provide that the Participant will receive a cash settlement equal to the Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section&nbsp;409A Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) If the Change in Control is not also a Section&nbsp;409A Change of Control, then the Acquiring Entity must either assume, continue or
substitute each Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award. The shares to be issued in respect of the Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be issued to the Participant by the Acquiring Entity on
the same schedule that the shares would have been issued to the Participant if the Change in Control had not occurred. In the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash
payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of the Fair Market Value of the shares made on the date of the
Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards. The following
provisions shall apply to any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award unless otherwise determined by the Board pursuant to Section&nbsp;12(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) In the event of a Change in Control, the Acquiring Entity shall assume, continue or substitute any Unvested <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Unless otherwise determined by the Board, any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award will remain subject to the same vesting and forfeiture restrictions that were
applicable to the Award prior to the Change in Control. The shares to be issued in respect of any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be issued to the Participant by the Acquiring Entity on the same schedule that
the shares would have been issued to the Participant if the Change in Control had not occurred. In the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each
applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value of the shares made on the date of the Change in Control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) If the Acquiring Entity will not assume, substitute or continue any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT>
Award in connection with a Change in Control, then such Award shall automatically terminate and be forfeited upon the Change in Control with no consideration payable to any Participant in respect of such forfeited Unvested <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award. Notwithstanding the foregoing, to the extent permitted and in compliance with the requirements of Section&nbsp;409A, the Board may in its discretion determine to elect to accelerate the vesting and
settlement of the Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award upon the Change in Control, or instead substitute a cash payment equal to the Fair Market Value of such shares that would otherwise be issued to the Participant, as
further provided in Section&nbsp;12(e)(ii) below. In the absence of such discretionary election by the Board, any Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall be forfeited without payment of any consideration to the
affected Participants if the Acquiring Entity will not assume, substitute or continue the Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards in connection with the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) The foregoing treatment shall apply with respect to all Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards upon any
Change in Control, and regardless of whether or not such Change in Control is also a Section&nbsp;409A Change of Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)<B>
Treatment of <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Awards Upon a Change in Control for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors.</B> The following provisions of this Section&nbsp;12(d) shall apply and shall
supersede anything to the contrary that may be set forth in the Plan with respect to the permitted treatment of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award in connection with a Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Change in Control is also a Section&nbsp;409A Change of Control, then the Acquiring Entity may not assume, continue or substitute
the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Upon the Section&nbsp;409A Change of Control the vesting and settlement of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award will automatically be accelerated
and the shares will be immediately issued to the Participant in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Alternatively, the Company may provide that the Participant will instead receive a cash settlement
equal to the Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section&nbsp;409A Change of Control pursuant to the preceding provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If the Change in Control is not also a Section&nbsp;409A Change of Control, then the Acquiring Entity must either assume, continue or
substitute the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award. Unless otherwise determined by the Board, the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award will remain subject to the same vesting and forfeiture
restrictions that were applicable to the Award prior to the Change in Control. The shares to be issued in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award shall be issued to the Participant by the Acquiring Entity on
the same schedule that the shares would have been issued to the Participant if the Change in Control had not occurred. In the Acquiring Entity&#146;s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash
payment on each applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination of Fair Market Value made on the date of the Change in Control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If the RSU Award is a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award, then the provisions in this Section&nbsp;12(e) shall
apply and supersede anything to the contrary that may be set forth in the Plan or the Award Agreement with respect to the permitted treatment of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Any exercise by the Board of discretion to accelerate the vesting of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award shall not
result in any acceleration of the scheduled issuance dates for the shares in respect of the <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award unless earlier issuance of the shares upon the applicable vesting dates would be in compliance with
the requirements of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The Company explicitly reserves the right to earlier settle any <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award to the extent permitted and in compliance with the requirements of Section&nbsp;409A, including pursuant to any of the exemptions available in Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(j)(4)(ix).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To the extent the terms of any <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award provide that it will be settled upon a Change in Control or Change of Control, to the extent it is required for compliance with the requirements of Section&nbsp;409A, the Change in Control or Change
of Control event triggering settlement must also constitute a Section&nbsp;409A Change of Control. To the extent the terms of a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award provides that it will be settled upon a termination of
employment or termination of Continuous </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Service, to the extent it is required for compliance with the requirements of Section&nbsp;409A, the termination event triggering settlement must also constitute a Separation From Service.
However, if at the time the shares would otherwise be issued to a Participant in connection with a &#147;separation from service&#148; such Participant is subject to the distribution limitations contained in Section&nbsp;409A applicable to
&#147;specified employees,&#148; as defined in Section&nbsp;409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date that is six months following the date of the Participant&#146;s Separation From Service, or, if earlier, the
date of the Participant&#146;s death that occurs within such six month period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) The provisions in Section&nbsp;12(e) for delivery of
the shares in respect of the settlement of a RSU Award that is a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award are intended to comply with the requirements of Section&nbsp;409A so that the delivery of the shares to the Participant in
respect of such <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award will not trigger the additional tax imposed under Section&nbsp;409A, and any ambiguities herein will be so interpreted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.<B> Severability.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If all or any part of the Plan or any
Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid. Any Section of
the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible
while remaining lawful and valid. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14.<B> Termination of the Plan.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of: (i)&nbsp;the
Adoption Date, or (ii)&nbsp;the Effective Date. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15.<B>
Definitions.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in the Plan, the following definitions apply to the capitalized terms indicated below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B><I>Acquiring Entity</I></B>&#148; means the surviving or acquiring corporation (or its parent company) in connection with a
Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Adoption Date</I></B>&#148; means the date the Plan is first approved by the Compensation Committee of
the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or &#147;subsidiary&#148;
of the Company as such terms are defined in Rule 405 promulgated under the Securities Act. The Board may determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Annual Meeting</I></B>&#148; means the annual meeting of stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B><I>Applicable Law</I></B>&#148; means shall mean any applicable securities, federal, state, foreign, material local or municipal
or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put
into effect by or under the authority of any Governmental Body (or under the authority of the NASDAQ Stock Market or the Financial Industry Regulatory Authority). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B><I>Appreciation Award</I></B>&#148; means (i)&nbsp;a stock option or stock appreciation right granted under any of the Prior
Plans or (ii)&nbsp;an Option or SAR granted under the Plan, in each case with respect to which the exercise or strike price is at least 100% of the Fair Market Value of the Common Stock subject to the option or stock appreciation right, as
applicable, on the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B><I>Automatic Grant Program</I></B>&#148; means the grant program in effect for Eligible
Directors under Section&nbsp;7 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B><I>Award</I></B>&#148; means any right to receive Common Stock granted under the
Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, a SAR, a Performance Award or any Other Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B><I>Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the terms and
conditions of an Award. The Award Agreement generally consists of the Grant Notice and General Terms and Conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. Any decision or determination made by the Board shall be a decision or determination that is made in the sole discretion of the Board (or its designee), and such decision
or determination shall be final and binding on all Participants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) &#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or
other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization,
reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar
equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible
securities of the Company will not be treated as a Capitalization Adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) &#147;<B><I>Cause</I></B>&#148; has the meaning
ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events that has a
material negative impact on the business or reputation of the Company: (i)&nbsp;such Participant&#146;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (ii)&nbsp;such Participant&#146;s intentional,
material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iii)&nbsp;such Participant&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or
trade secrets; or (iv)&nbsp;such Participant&#146;s gross misconduct. The determination that a termination of the Participant&#146;s Continuous Service is either for Cause or without Cause will be made by the Board with respect to Participants who
are executive officers of the Company and by the Company&#146;s Chief Executive Officer with respect to Participants who are not executive officers of the Company. Any determination by the Company that the Continuous Service of a Participant was
terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) &#147;<B><I>Change in Control</I></B>&#148; or &#147;<B><I>Change of Control</I></B>&#148; means the occurrence, in a single transaction
or in a series of related transactions, of any one or more of the following events constituting a change in ownership or control of the Company; provided, however, to the extent necessary to avoid adverse personal income tax consequences to the
Participant in connection with an Award, such transaction also constitutes a Section&nbsp;409A Change of Control: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a merger,
consolidation or other reorganization approved by the Company&#146;s stockholders, unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately
thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company&#146;s outstanding voting securities immediately prior to such transaction, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a stockholder-approved sale, transfer or other disposition of all or substantially all of the Company&#146;s assets in complete
liquidation or dissolution of the Company, or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the closing of any transaction or series of related transactions pursuant to which
any person or any group of persons comprising a &#147;group&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> of the Exchange Act (other than the Company or a person that, prior to such transaction or series of
related transactions, directly or indirectly controls, is controlled by or is under common control with, the Company) becomes directly or indirectly the beneficial owner (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of
the Exchange Act) of securities possessing (or convertible into or exercisable for securities possessing) more than fifty percent (50%) of the total combined voting power of the Company&#146;s securities (as measured in terms of the power to vote
with respect to the election of Board members) outstanding immediately after the consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of
outstanding securities held by one or more of the Company&#146;s existing stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing or any other
provision of this Plan, (A)&nbsp;the term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&nbsp;the definition of Change in
Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards subject to such agreement; <I>provided, however</I>, that
(1)&nbsp;if no definition of Change in Control (or any analogous term) is set forth in such an individual written agreement, the foregoing definition shall apply; and (2)&nbsp;no Change in Control (or any analogous term) will be deemed to occur with
respect to Awards subject to such an individual written agreement without a requirement that the Change in Control (or any analogous term) actually occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) &#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) &#147;<B><I>Committee</I></B>&#148; means the Compensation Committee and any other committee of Directors to whom
authority has been delegated by the Board or Compensation Committee in accordance with Section&nbsp;8(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) &#147;<B><I>Common
Stock</I></B>&#148; means the common stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) &#147;<B><I>Company</I></B>&#148; means Sangamo Therapeutics, Inc., a
Delaware corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) &#147;<B><I>Compensation Committee</I></B>&#148; means the Compensation Committee of the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) &#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is
(i)&nbsp;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However,
service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only
if a Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) &#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s service with the Company or an Affiliate, whether as an
Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the
Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a Participant&#146;s Continuous Service; <I>provided, however,</I> that if
the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant&#146;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an
Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the chief executive
officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any leave of absence approved by the Board or chief executive officer, including sick
leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an
Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent
required for exemption from or compliance with Section&nbsp;409A, the determination of whether there has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with the definition of
&#147;separation from service&#148; as defined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> (without regard to any alternative definition thereunder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) &#147;<B><I>Director</I></B>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) &#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, such Participant is unable to engage in any substantial gainful
activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in
Section&nbsp;22(e)(3) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) &#147;<B><I>Effective Date</I></B>&#148; means the date of the Annual Meeting in 2018, provided this Plan is approved by the
Company&#146;s stockholders at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) &#147;<B><I>Eligible Director</I></B>&#148; means a Director who is not an Employee.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) &#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However, service solely as a Director,
or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)
&#147;<B><I>Employer</I></B>&#148; means the Company or the Affiliate of the Company that employs the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)
&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the
value of the Common Stock (as determined on a per share or aggregate basis, as applicable) determined as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair
Market Value will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board
deems reliable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If there is no closing sales price for the Common Stock on the date of determination, then
the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;In the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market
Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Full Value Award</I></B>&#148; means an Award granted under the Plan or an award granted under the
Prior Plans that is not an Appreciation Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>General Terms and Conditions</I></B>&#148; means the
written summary of the general terms and conditions applicable to an Award and which is provided to a Participant along with the Grant Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Governmental</I></B> <B><I>Body</I></B>&#148; means any: (a)&nbsp;nation, state, commonwealth,
province, territory, county, municipality, district or other jurisdiction of any nature; (b)&nbsp;federal, state, local, municipal, foreign or other government; (c)&nbsp;governmental or regulatory body, or quasi-governmental body of any nature
(including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the
avoidance of doubt, any Tax authority) or other body exercising similar powers or authority; or (d)&nbsp;self-regulatory organization (including the Nasdaq Stock Market and the Financial Industry Regulatory Authority). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Grant Notice</I></B>&#148; means the written notice provided to a Participant that he or she has been
granted an Award under the Plan and which includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject to the Award (if any), the vesting schedule for the Award (if any) and other
key terms applicable to the Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Hostile Take-Over</I></B>&#148; means a change in ownership or
control of the Company effected through either of the following transactions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;a change in the composition of
the Board over a period of <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;consecutive months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised
of individuals who either (A)&nbsp;have been Board members continuously since the beginning of such period or (B)&nbsp;have been elected or nominated for election as Board members during such period by at least a majority of the Board members
described in clause (A)&nbsp;who were still in office at the time the Board approved such election or nomination, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;a Hostile Tender-Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Hostile Tender-Offer</I></B>&#148; means the acquisition, directly or indirectly, by any person or
related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company&#146;s outstanding securities pursuant to a tender or exchange offer made
directly to the Company&#146;s stockholders which the Board does not recommend such stockholders to accept. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Incentive Stock Option</I></B>&#148; means an option granted pursuant to Section&nbsp;4 of the Plan
that is intended to be, and qualifies as, an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B>&#148; means a Director who
either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than
as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the Securities Act (&#147;<B><I>Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a
business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation <FONT STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT>
director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award</I></B>&#148; means any Award that is subject to, and not exempt from, Section&nbsp;409A, including as the result of (i)&nbsp;a deferral of the issuance of the shares subject to the Award which is
elected by the Participant or imposed by the Company, or (ii)&nbsp;the terms of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Director Award</I></B>&#148; means a <FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Award granted to a Participant who was a Director but not an Employee on the applicable grant date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Severance Arrangement</I></B>&#148; means a
severance arrangement or other agreement between the Participant and the Company that provides for acceleration of vesting of an Award and issuance of the shares in respect of such Award upon the Participant&#146;s termination of employment or
separation from service (as such term is defined in Section&nbsp;409A(a)(2)(A)(i) of the Code (and without regard to any alternative definition thereunder) (&#147;<B><I>Separation from Service</I></B>&#148;) and such severance benefit does not
satisfy the requirements for an exemption from application of Section&nbsp;409A provided under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4),</FONT> <FONT STYLE="white-space:nowrap">1.409A-1(b)(9)</FONT> or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any option granted pursuant to
Section&nbsp;4 of the Plan that does not qualify as an Incentive Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of
Section&nbsp;16 of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option</I></B>&#148; means an Incentive Stock Option or a
Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Option Agreement</I></B>&#148; means a written
agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant and which includes the Option Grant Notice and the Option Terms and Conditions. Each Option Agreement will be subject to the terms and
conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted
pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other
Award</I></B>&#148; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(uu)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Other Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of an
Other Award evidencing the terms and conditions of an Other Award grant. Each Other Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vv)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Own,</I></B>&#148; &#147;<B><I>Owned,</I></B>&#148; &#147;<B><I>Owner,</I></B>&#148;
&#147;<B><I>Ownership</I></B>&#148; means that a person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired &#147;Ownership&#148; of securities if such person or Entity,
directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ww)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Participant</I></B>&#148; means an Employee, Director or Consultant to whom an Award is granted
pursuant to the Plan or, if applicable, such other person who holds an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Award</I></B>&#148; means an Award that may vest or may be exercised contingent upon the
attainment during a Performance Period of certain Performance Goals and which is granted under the terms and conditions of Section&nbsp;5(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(yy)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that the Board will select for
purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board:
(i)&nbsp;earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;earnings before interest, taxes,
depreciation, amortization and legal settlements; (v)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal
settlements, other income (expense) and stock-based compensation; (vii)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue;
(viii)&nbsp;total stockholder return; (ix)&nbsp;return on equity or average stockholder&#146;s equity; (x)&nbsp;return on assets, investment, or capital employed; (xi)&nbsp;stock price; (xii)&nbsp;profit (including gross profit) and/or margin
(including gross margin); (xiii) income (before or after taxes); (xiv) operating income; (xv)&nbsp;operating income after taxes; <FONT STYLE="white-space:nowrap">(xvi)&nbsp;pre-tax</FONT> profit; (xvii)&nbsp;operating cash flow; (xviii)&nbsp;sales
or revenue targets; (xix)&nbsp;increases in revenue or product revenue; (xx)&nbsp;expenses and cost reduction goals; (xxi)&nbsp;improvement in or attainment of working capital levels; (xxii)&nbsp;economic value added (or an equivalent metric);
(xxiii) market share; (xxiv)&nbsp;cash flow; (xxv)&nbsp;cash flow per share; (xxvi)&nbsp;share price performance; (xxvii)&nbsp;debt reduction; (xxviii)&nbsp;implementation or completion of projects or processes; (xxix)&nbsp;employee retention;
(xxx)&nbsp;stockholders&#146; equity; (xxxi)&nbsp;capital expenditures; (xxxii)&nbsp;debt levels; (xxxiii)&nbsp;operating profit or net operating profit; (xxxiv)&nbsp;workforce diversity; (xxxv)&nbsp;growth of net income or operating income;
(xxxvi)&nbsp;billings; (xxxvii) bookings; and (xxxviii)&nbsp;other measures of performance selected by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(zz)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by
the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms
or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i)&nbsp;in the Award Agreement at the time the Award is granted or (ii)&nbsp;in such
other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows:
(1)&nbsp;to exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory
adjustments to corporate tax rates; (5)&nbsp;to exclude the effects of items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (6)&nbsp;to exclude the dilutive
effects of acquisitions or joint ventures; (7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8)&nbsp;to exclude the
effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT>
combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under the
Company&#146;s bonus plans; (10)&nbsp;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to expensed under generally accepted accounting principles; and (11)&nbsp;to exclude the goodwill and
intangible asset impairment charges that are required to be recorded under generally accepted accounting principles. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of
Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of
achievement as specified in the Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aaa)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Performance Period</I></B>&#148; means the period
of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to vesting or exercise of an Award. Performance Periods may be of varying and
overlapping duration, at the sole discretion of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bbb)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Plan</I></B>&#148; means this Sangamo
Therapeutics, Inc. 2018 Equity Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ccc)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Plan Administrator</I></B>&#148; means the
person, persons, and/or third-party administrator designated by the Company to administer the day to day operations of the Plan and the Company&#146;s other equity incentive programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ddd)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Post-Termination Exercise Period</I></B>&#148; means the period following termination of a
Participant&#146;s Continuous Service within which an Option or SAR is exercisable, as specified in Section&nbsp;4(g). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(eee)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Predecessor Plan</I></B>&#148; means the Company&#146;s Amended and Restated 2013 Stock Incentive
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(fff)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Prior Plans</I></B>&#148; means the Predecessor Plan and the Company&#146;s 2004 Stock
Incentive Plan (together). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ggg)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Prior Plans&#146; Returning Shares</I></B>&#148; means shares of
Common Stock subject to outstanding stock awards granted under the Prior Plans and that following the Effective Date: (A)&nbsp;are not issued because such stock award or any portion thereof expires or otherwise terminates without all of the shares
covered by such stock award having been issued; (B)&nbsp;are not issued because such stock award or any portion thereof is settled in cash; or (C)&nbsp;are forfeited back to or repurchased by the Company because of the failure to meet a contingency
or condition required for the vesting of such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hhh)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Predecessor Plan&#146;s Available
Reserve</I></B>&#148; means the number of shares available for the grant of new awards under the Predecessor Plan as of immediately prior to the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Prospectus</I></B>&#148; means the document containing the Plan information specified in
Section&nbsp;10(a) of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jjj)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of
shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kkk)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Restricted Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a
holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lll)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>RSU Award</I></B>&#148; means an Award of restricted stock units representing the right to receive an
issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;5(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mmm)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>RSU Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a RSU
Award evidencing the terms and conditions of a RSU Award grant. Each RSU Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nnn)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ooo)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Rule 405</I></B>&#148; means Rule 405 promulgated under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ppp)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148; means Section&nbsp;409A of the Code and
the regulations and other guidance thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qqq)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A
Change of Control</I></B>&#148; means a change in the ownership or effective control of the Company, or in the ownership of a substantial portion of the Company&#146;s assets, as provided in Section&nbsp;409A(a)(2)(A)(v) of the Code and Treasury
Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rrr)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(sss)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Share Reserve</I></B>&#148; means the number of shares available for issuance under the Plan as set
forth in Section&nbsp;2(a), subject to adjustment pursuant to Section&nbsp;6(a) in connection with Capitalization Adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ttt)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>SAR</I></B>&#148; or &#147;<B><I>Stock Appreciation Right</I></B>&#148; means a right to receive the
appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(uuu)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>SAR Agreement</I></B>&#148; means a written agreement between the Company and a holder of a SAR
evidencing the terms and conditions of a SAR grant. Each SAR Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vvv)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Ten Percent Stockholder</I></B>&#148; means a person who Owns (or is deemed to Own pursuant to
Section&nbsp;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(www)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Trading Policy</I></B>&#148; means the
Company&#146;s policy permitting certain individuals to sell Company shares only during certain &#147;window&#148; periods and/or otherwise restricts the ability of certain individuals to transfer or encumber Company shares, as in effect from time
to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxx)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Unvested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award</I></B>&#148; means
the portion of any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award that had not vested in accordance with its terms upon or prior to the date of any Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(yyy)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B><I>Vested <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award</I></B>&#148; means the portion of
any <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Award that had vested in accordance with its terms upon or prior to the date of a Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sgmo-20200518.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-3 Build:20200324.2 -->
<!-- Creation date: 5/22/2020 11:08:29 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:sgmo="http://www.sangamo.com/20200518"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.sangamo.com/20200518"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20200518_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20200518_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sgmo-20200518_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-3 Build:20200324.2 -->
<!-- Creation date: 5/22/2020 11:08:29 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sgmo-20200518_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-3 Build:20200324.2 -->
<!-- Creation date: 5/22/2020 11:08:30 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="sgmo-20200518.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g935677ex31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g935677ex31.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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2@;G8]@!A55044 >H4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6628443712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 18, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANGAMO THERAPEUTICS, INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001001233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 18,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0359556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Marina Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">970-6000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O*FR=-GOSCXTO@ET+O^ZB^P)02P,$%     @ QH6V4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M_VTP",\.&C'._MAL]3T[MU9.[Z5HM8*XEM\63&XL6&1\K4,ZX\2KYPLWI?(
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MA@8MU&\\(##.(50;+^*1=*:W=Y-[#KO7^H&Q=_OJ5-*/&N/'+7\ 4$L#!!0
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MK_>PGPG;83UVX=\@J6$Z[];_:'29RZ!=_,W(1TKM05\-_\GR"U!+ 0(4 Q0
M   ( ,:%ME ?(\\#P    !,"   +              "  0    !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ,:%ME GZ(<.@@   +$    0              "
M >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ QH6V4/OJ1TKO
M*P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ QH6V4)E<G",0!@  G"<  !,              ( !MP(  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #&A;90_Q4?J:8"  #Y"P  &
M            @ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ QH6V4%24:.!P @  / 8  !0              ( !U L  'AL+W-H
M87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ QH6V4+JA.8K7 0  ,@8   T
M             ( !=@X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #&A;90
M%FTC?T,!   \ @  #P              @ %X$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ QH6V4/_ )@B]    A0(  !H              ( !Z!$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ QH6V4 N/
MV ,A 0  5P0  !,              ( !W1(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      H "@"  @  +Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d935677d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d935677d8k.htm">d935677d8k.htm</File>
    <File>d935677dex101.htm</File>
    <File>d935677dex31.htm</File>
    <File>sgmo-20200518.xsd</File>
    <File>sgmo-20200518_lab.xml</File>
    <File>sgmo-20200518_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d935677d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d935677d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgmo-20200518_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmo-20200518_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "sgmo-20200518.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sgmo",
   "nsuri": "http://www.sangamo.com/20200518",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d935677d8k.htm",
      "contextRef": "duration_2020-05-18_to_2020-05-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d935677d8k.htm",
      "contextRef": "duration_2020-05-18_to_2020-05-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com//20200518/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-20-150198-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-150198-xbrl.zip
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ME&JE4GDE?;<R(M7#L"')HO@3:1<0BSN @EWR'P#!PN02I+\6%$@V,O#^/&[
M/AVKU"=D1,L9#+@0>Z<[&BP2J-1[)_G%78>T!T/+&3-WOT2_.%\@N;0]\ ^B
MPAWA0VE_#Q(@UFHI<)MZN*9INDR(\,<E1"O:QMZM NB!7%&7VY1\L1[-W+R3
M4U8O$<R,H@6_WKCWSI.]\1B^@"_I4GL!$2;M6OJF&_<60":7V]Z[AJPM8"-4
MLCE-OHT[,\);!YYI_9L/MX'49[6BJI8^,O@(J8B1_A DU>!#:A$V8H;O\4=<
M  "(Q\0G<@(4)DCB5>;QK51Y<4%FI9R@WC2!55M)QDE)4S\EE\E+!]A[VW?L
M;4.-6D7-EL%B+%^JVYM\3)>O?OFIJFN5AB >L]@09TIL.54%4:+EHS03"#XI
MS!S$9+J^LD?1N'8\TAP.+= ]$-(]D_(KV$+ ]]=R8<TEX<=0 8&(/=*2B]XF
MZ:"M)9=4>.%R\PPUCWF1+1GU=\#Y5I\9/^2V AV"OP';AD%6UQF1+K.<)Z0V
M%B(32#7[&^EQ"^67"Q!FC]DF<,%SB. #W_+ ?SJ^L,9$@!*+WEBV#!LX71BF
MU&T2;F/$%DQ]>(Y+J#V.RGH ^9PG;(<^D&.H(>IS8KEV;N7)%OA+X>@*TL]C
MT^B7.$]0@.+0=$/P%?81>+Y$SG7>G09]%W]N+/&K3WWN,0FA&9C1)Y<.&_-K
M]DD5WT;P8JUQ,/]TN0?"@G&C;X=+(>+%&*GK.%:7@J!X(*ZH0[5*L=A8] MR
MM^"7GPKZLI OH7I)5F[*O\Q9.'&8:7SF9!C;9KSS03:+>BE4@KD-/MS7.]$J
MI/7UCN@%-0<5/ZT%%:E6'(U6=,"'&,!F^^$*;"X87NLCJ,1TUF003GM1'[0B
MS6IZ3"5F-KHG"E%4<T'-5"?>B4[<N@R]!.9OR@0=1!CN3:^W>:!PC+H!L\\:
ML>D_ZS>THIG53[J?DFE*4#?5E?>I*Q="^,Q-->89C2FP;/'$2*8Q8=WU&K/#
M"2Z&9S$H&,1+S(6(:[@L34W:@3!^@IG4=Z*G:;+&+I(UEBUUSJ\I>/-K"HN6
M9,[>!$WWNBQZC\>N@NP^HT\,BPJ1;"-N,O:5>W'/T>< B>%25*?]KIYUQ@-X
MTHE(N"'Z'OEP'6;D29EDH7'?<X: 34"?83A3(_ZRS9/WLHL8^K>QIG>E+=EX
M.P 1$%"WXSG&#X7\GYI3-0*>B3Q2RV=DB*>S^FFFUX3>H8T*K,3F1TN_7=VD
ME)R5W @];G-6=P%QH[6*=GROJ3#IW^2;Y0 &!YAG =##;?(?S%N_$?O6&/7"
M-A%O,](=$T-N)T"-'V#PF,S3FEOKYX) + 1@'1_R0!Y<Y\GK(VP?XOH_%<1D
M/6X'B=/!VJA:(HLG'Z8''@KD!.6JTI 1B%PDC5IPF7<]Q+QKW$D* @"]F]67
M/'#948KHR4$T,&T8>VYN \<21[N CN<)+S]S&Q,&Z\_'M8M\:"^G::!TH>J]
M2B :Y!E$W7^3O;>"SM\V!MV %R^7^MX:.<:MWJ5*P1?VOOH@\E*W0>1M1X9T
MOF"R%@PQW&'#VQNX#/."X[I()MF7-<;.GSATC>ICP_R@Q&6/7$ [4"1J&[C"
M2@T#$ZJQ,E[,8%+7%,'>FKDJGBR<T$D\&5>.W,X$:L+,9<Q;RP%-G1YQ3<\2
M;W>6&/]==:Y8TI@-YN?(!IFSV",(.''TXZM:DX7F#1*#MET&4@S0UGJB8Y$)
MSO/@[1X3&&PXEN/6?ZK)/XT)<4:QF0>W=\B!;'D6_956,A>PR!$M;6IJ\K7-
M"X\- MDJY52=;+@ N ZQ;;DB>(X+4Y[ORA#PG+M@SAQ7H%5LP90HH(H;F:OE
MB@9I6Z&QBU=M8":,PVU/KB="R6([=&[,%A2JCTG3==$T8FVQK'HNH$D0YKT0
MF\4A0G$SB"#7[F]L0) A(HC./"J$>D$"B&W[X"H ?4H_ 5,1&%7U@2\P#7*"
M=3"Y25<;S:#J55!5?JDUI+?H!/<UD7N ?G3(?! BH9 +V\C-/* 589.@I2('
M$/M2)E#-="_34Q[1&>)0HPMJ8- FN#N9+AGQ2P*[U</05:U*VG_[ %GP"SR>
M\<C(K05^+#Y"60V_G<S.<X!4$&P^A <0/#RS+V16%VA6Z+.#5"])/(P[132@
M^;D90=PJIX@38"[.#=TZ%^B+#19;H9Z,!=%$3:FIJH(YLV$/,XP9!(@!R7(7
MD,4D"U/);7)V<H<RJ$E7=(\+U&O'"<@$$$R02]2G)NE"0#01 (4(O_L?#(8P
M\6@J(F$%:BE(I8CF4DU1Q>6A!<]C+.+(%P= T)R1F.'5#&%E[2G]$LRARPQ<
MB&*]'AH9$#$^&# 3TZM@5OXP8O[<X"-EG-6P_3,,\,I@0J!GN2=QI91FK/X@
M@6YP2B94MT#NG:'<I5$ ^.)]89XO#>I<6? 1Z<, RDI>RNT!*$+%!_B/O8>U
MGA#8+BGP;>Y-2@/UG6V!4P%L+<,/5+YX*4P"N#*@8^ I$<SSK" \-:CHA^-3
MIN>2,(L.7,!XOSQKD@& *PBFP1?A<(4_@#J3!+M)ZD6/4726"5D;3V'UXE(1
MY]G$)B]R0$H"TI.Y3)HW!3-AD:8H+!#$ %6764NY)L"EY !Y1R@CD<&/A&Q6
M83#M$+J6@=%<H(^CF\0STZ-,!/YO#EUN!=Y1#YSCC VXE5UWHJ[CUL !\Q^0
M..HB2&.$0,_!X9A,&"X/1%I.^6\?$_K# ^)0E[L$5<-EX)7 ?$UNL4(C)Q_E
M6Q:1UU8ET\%@N9F+D! 4%SCZO L\T-2<1I !\&1L+%,YH]-K4!6+N#TSB 51
M7B^ U==.$_B0X+IP .!Z<C&@0+ELXBRLP';,G.!&8_AE;-$GQ,J!HH%$!=?>
M$;SW[I P<7.9P]T$D*(241-L7PA.OSH^FC*, X*#OQ)R3$@W8U*>J1M'ULL&
MU)&7J?27&X.YA\YP2$&+0(-6"O)R!L1ZC@>DF$)9")7[C@LT-6.H=@;!]EPG
ME%3XB^ 4_P9?A"T\)_A8T)>6[Q_A/,>VW6!2B2/W#0TFJ, $E?1#]]=+)+S@
M+1:\]9Q?#!0"Y&,X#CP](K\ECJB0^J%C]$.5 _!#';\[@6T]<D4AKG.E2Z+D
M#R<0V6A_CGP/[/61N)R9DR]#1U!+D">0_JF["0U)W!?5R0D/CS[)?8/8LI9<
MD^!X!LT9P ^8%@)F,PQYB879".8J149CA@L3B(VG(3/N(UC!@Q&//K-L!,^
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M%'NFV//UL&>UHE3A;R7YVR .'MCH2JU64LKJ^TD!T!2U4%1JE?>S4+LE^$R
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M@W-BI&E(M*S5"D4E;(B)!BX^JH_G]'UK3 SJXTE]D%<!Y0"293==1@1,  H
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MZ=;TABAI$;9SI.FNH$$OI7.8Y+_ G:$>V%%(3B-R&Z*16L"#UK(N/>]7@XB
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M+9D#B*MX,NO&_=-86-WRX+@6FSL%#VQ8VYZXT FU5(;3L"VZ<ZCZYX+>N61
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MDPFA06F]DP="HQ1VT<:D1+#W'U#OCX<1>Q,><!_G3O=!4]1G :?:Y=ADLK1
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M<W%/P:-FRJSGYO%@NLQ*XH,>%_ \;OCM P\]/:1C4&*?HIICE KN0R)YUT>
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M?SP\[?#CP%2FC)!/7;*\6\VRB#']2.%W"/XEL8W[WYVF&\_WBO M[P!%24E
MFPI\#W4]6PN7<+?/%BQ_[5C&?*W) O?8)5F?,[W?5F96RD(;=E8Y.,S%E:)I
MS:6B+KH1I:MM8*=^9)IY3Z&J80NX3>02%Z-XD1W5 CI,M^1:>'A4C8X>?YY=
M%IL=JXE#";%+QR/?Z.BA;72TCX]L=ZRPI2A2]O^W=S6M"0-!]"[X'[P(%CQH
M"#T61 \]5)0D%GHLJ>!!$O%@\-\[LS.;S&ZS=C%I0Z#@*;!Q<!?WS>[[:-A
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MN7'-3"_WI/G]/0DF9;/Z@(>OR?KMY0902P,$%     @ QH6V4!N776(<!@
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MMXXW0+KI>-:-I6N>B>P;I(W,L0&_GFAX _,Y=+^2G@(XU_P,& 8I'-- VMA
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MC&S@DO* AS1@<)>7_ :N>-B',\;@DTE3NDY%Y .)^ADJH_S?D?DR-=7#ZU<
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M'+?BU[FU.UJS6 P[FE_S9;=SP1L^7MS-Z\B6I0*$_;J+/>U82!9-P"%!QWK
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M-C<W9#AK+FAT;5!+ 0(4 Q0    ( ,:%ME#)2]#L3WP   "/ @ 1
M      "  =88  !D.3,U-C<W9&5X,3 Q+FAT;5!+ 0(4 Q0    ( ,:%ME ;
MEUUB' 8  ,D4   0              "  525  !D.3,U-C<W9&5X,S$N:'1M
M4$L! A0#%     @ QH6V4'RIN1%B P  ) P  !$              ( !GIL
M '-G;6\M,C R,# U,3@N>'-D4$L! A0#%     @ QH6V4!LWANF7!@  /$<
M !4              ( !+Y\  '-G;6\M,C R,# U,3A?;&%B+GAM;%!+ 0(4
M Q0    ( ,:%ME *<@!GV 0  ,LL   5              "  ?FE  !S9VUO
G+3(P,C P-3$X7W!R92YX;6Q02P4&      8 !@!^ 0  !*L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>d935677d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgmo-20200518.xsd" xlink:type="simple"/>
    <context id="duration_2020-05-18_to_2020-05-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2020-05-18</startDate>
            <endDate>2020-05-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-05-18_to_2020-05-18"
      id="Hidden_dei_EntityRegistrantName">SANGAMO THERAPEUTICS, INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-05-18_to_2020-05-18">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-05-18_to_2020-05-18"
      id="Hidden_dei_EntityCentralIndexKey">0001001233</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2020-05-18_to_2020-05-18"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2020-05-18_to_2020-05-18">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2020-05-18_to_2020-05-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-05-18_to_2020-05-18">2020-05-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-05-18_to_2020-05-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-05-18_to_2020-05-18">000-30171</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-05-18_to_2020-05-18">68-0359556</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-05-18_to_2020-05-18">7000 Marina Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-05-18_to_2020-05-18">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-05-18_to_2020-05-18">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-05-18_to_2020-05-18">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-05-18_to_2020-05-18">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-05-18_to_2020-05-18">970-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-05-18_to_2020-05-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-05-18_to_2020-05-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-05-18_to_2020-05-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-05-18_to_2020-05-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-05-18_to_2020-05-18">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-05-18_to_2020-05-18">SGMO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-05-18_to_2020-05-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-05-18_to_2020-05-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
